Skip to main content
Fig. 2 | Radiation Oncology

Fig. 2

From: An esophagus-sparing technique to limit radiation esophagitis in locally advanced non-small cell lung cancer treated by simultaneous integrated boost intensity-modulated radiotherapy and concurrent chemotherapy

Fig. 2

a Grade of esophagitis for esophagus-sparing group and non-sparing group. The grade of RE (p = 0.002) had statistical significance between two groups. Patients had lower incidence of RE in the esophagus sparing group. b, c represent Subjective Global Assessment (SGA) score for esophagus-sparing group and non-sparing group. b SGA before treatment. c SGA after treatment. Patients in two groups had comparable SGA scores before treatment (p = 0.670). However, post-treatment SGA score (p = 0.045) showed significant association with the use of esophagus sparing. Patients in esophagus-sparing group had better nutrition status

Back to article page